This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Web of Science (1) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Wijesinghe, L. D. Articles by Scott, D. J. A. Search for Related Content PubMed Articles by Wijesinghe, L. D. Articles by Scott, D. J. A. Social Bookmarking                         What's this?

Implications of Serum Cholesterol Measurement for the Vascular Surgeon

Ishtiaq Mehmood Ahmed, MB, ChB

Department of Vascular and Endovascular Surgery, St. James's University Hospital, Beckett Street, Leeds, England

Stephen Gilbey, MRCP

Department of Endocrinology, St. James's University Hospital, Beckett Street, Leeds, England

David Charles Berridge, FRCS

David Julian Ashbridge Scott, FRCS

Department of Vascular and Endovascular Surgery, St. James's University Hospital, Beckett Street, Leeds, England

Objective: To measure the serum total cholesterol in new patients with intermittent claudication and to assess the proportion with ischemic heart disease and untreated hypercholesterolemia.

Design: A prospective study with patient history corroborated by a general practitioner telephone questionnaire.

Setting: A vascular surgical center in a major teaching hospital.

Subjects: Seventy-six consecutive claudicants were studied (median age, 66; range, 46 to 94; 45 men and 31 women), of whom 41 (54%) had ischemic heart disease.

Results: The median serum total cholesterol concentration was 6.35 mmol/L (IQR, 5.60 to 7.05 mmol/L). Forty-nine (65%) patients had never had their serum cholesterol assayed before this study despite 24 of them having ischemic heart disease.

Conclusions: Previously undiagnosed hypercholesterolemia is commonly revealed in the vascular surgical assessment of patients with intermittent claudication. The cardiac morbidity and mortality of these patients is high and surgeons should therefore be proactive in the instigation of cholesterol-lowering therapy.

Vascular and Endovascular Surgery, Vol. 32, No. 3, 241-244 (1998)
DOI: 10.1177/153857449803200306


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?